A number of clinical studies on AD patients revealed increased serum and tissue levels of IL-4 and IL-5, with a concomitant decrease in IFN-γ expression (Namkung et al., 2007; Vakirlis et al., 2011). The gene discussed is IFNG; the disease is Alzheimer disease.